1 M. Bhatia, F.L. Wong, Y. Cao, H.Y. Lau, J. Huang, P. Puneet, L. Chevali, Pathophysiology of acute pancreatitis, Pancreatology 5(2-3) (2005) 132-44.
2 J.L. Saloman, K.M. Albers, Z. Cruz-Monserrate, B.M. Davis, M. Edderkaoui, G. Eibl, A.Y. Epouhe, J.Y. Gedeon, F.S. Gorelick, P.J. Grippo, G.E. Groblewski, S.Z. Husain, K.K.Y. Lai, S.J. Pandol, A. Uc, L. Wen, D.C. Whitcomb, Animal Models: Challenges and Opportunities to Determine Optimal Experimental Models of Pancreatitis and Pancreatic Cancer, Pancreas 48(6) (2019) 759-779.
3 C. Shi, C. Hou, X. Zhu, D. Huang, Y. Peng, M. Tu, Q. Li, Y. Miao, SRT1720 ameliorates sodium taurocholate-induced severe acute pancreatitis in rats by suppressing NF-kappaB signalling, Biomed Pharmacother 108 (2018) 50-57.
4 S.L. McIlwrath, K.N. Westlund, Pharmacological attenuation of chronic alcoholic pancreatitis induced hypersensitivity in rats, World J Gastroenterol 21(3) (2015) 836-53.
5 B. Khatua, B. El-Kurdi, V.P. Singh, Obesity and pancreatitis, Curr Opin Gastroenterol 33(5) (2017) 374-382.
6 S.J. McPherson, D.A. O'Reilly, M.T. Sinclair, N. Smith, The use of imaging in acute pancreatitis in United Kingdom hospitals: findings from a national quality of care study, Br J Radiol 90(1080) (2017) 20170224.
7 P.A. Banks, M.L. Freeman, G. Practice Parameters Committee of the American College of, Practice guidelines in acute pancreatitis, Am J Gastroenterol 101(10) (2006) 2379-400.
8 M. Nesvaderani, G.D. Eslick, D. Vagg, S. Faraj, M.R. Cox, Epidemiology, aetiology and outcomes of acute pancreatitis: A retrospective cohort study, Int J Surg 23(Pt A) (2015) 68-74.
9 A.P. Rijkers, C.H. van Eijck, Acute Pancreatitis, N Engl J Med 376(6) (2017) 596-7.
10 J. Li, S. Zhang, R. Zhou, J. Zhang, Z.F. Li, Perspectives of traditional Chinese medicine in pancreas protection for acute pancreatitis, World J Gastroenterol 23(20) (2017) 3615-3623.
11 L. Zhu, J.Y. Li, Y.M. Zhang, H.X. Kang, H. Chen, H. Su, J. Li, W.F. Tang, Pharmacokinetics and pharmacodynamics of Shengjiang decoction in rats with acute pancreatitis for protecting against multiple organ injury, World J Gastroenterol 23(46) (2017) 8169-8181.
12 Q. Hu, S. Wei, J. Wen, W. Zhang, Y. Jiang, C. Qu, J. Xiang, Y. Zhao, X. Peng, X. Ma, Network pharmacology reveals the multiple mechanisms of Xiaochaihu decoction in the treatment of non-alcoholic fatty liver disease, BioData Min 13 (2020) 11.
13 S.B. Su, Y.Q. Li, H.Y. Shen, Y. Motoo, Effects of Chinese herbal medicines on spontaneous chronic pancreatitis in rats and the pathological relationships between formulas and syndromes, Zhong Xi Yi Jie He Xue Bao 4(4) (2006) 358-62.
14 S.K. Zhang, N.Q. Cui, Y.Z. Zhuo, D.H. Li, J.H. Liu, Modified Xiaochaihu Decoction () prevents the progression of chronic pancreatitis in rats possibly by inhibiting transforming growth factor-beta1/Sma- and mad-related proteins signaling pathway, Chin J Integr Med 19(12) (2013) 935-9.
15 J.F. Liu, A.N. Hu, J.F. Zan, P. Wang, Q.Y. You, A.H. Tan, Network Pharmacology Deciphering Mechanisms of Volatiles of Wendan Granule for the Treatment of Alzheimer's Disease, Evid Based Complement Alternat Med 2019 (2019) 7826769.
16 L. Zeng, K. Yang, H. Liu, G. Zhang, A network pharmacology approach to investigate the pharmacological effects of Guizhi Fuling Wan on uterine fibroids, Exp Ther Med 14(5) (2017) 4697-4710.
17 G. Yu, W. Wang, X. Wang, M. Xu, L. Zhang, L. Ding, R. Guo, Y. Shi, Network pharmacology-based strategy to investigate pharmacological mechanisms of Zuojinwan for treatment of gastritis, BMC Complement Altern Med 18(1) (2018) 292.
18 C.H. Wang, Y. Zhong, Y. Zhang, J.P. Liu, Y.F. Wang, W.N. Jia, G.C. Wang, Z. Li, Y. Zhu, X.M. Gao, A network analysis of the Chinese medicine Lianhua-Qingwen formula to identify its main effective components, Mol Biosyst 12(2) (2016) 606-13.
19 S.M. Li, S.J. Xu, S.M. Li, W.X. Hong, Study on clinical experience of using xiaochaihu decoction, Zhongguo Zhong Xi Yi Jie He Za Zhi 34(10) (2014) 1264-6.
20 Z. Junyuan, X. Hui, H. Chunlan, F. Junjie, M. Qixiang, L. Yingying, L. Lihong, W. Xingpeng, Z. Yue, Quercetin protects against intestinal barrier disruption and inflammation in acute necrotizing pancreatitis through TLR4/MyD88/p38MAPK and ERS inhibition, Pancreatology 18(7) (2018) 742-752.
21 J.Y. Seo, R.P. Pandey, J. Lee, J.K. Sohng, W. Namkung, Y.I. Park, Quercetin 3-O-xyloside ameliorates acute pancreatitis in vitro via the reduction of ER stress and enhancement of apoptosis, Phytomedicine 55 (2019) 40-49.
22 S.H. Kim, J.G. Park, G.H. Sung, S. Yang, W.S. Yang, E. Kim, J.H. Kim, V.T. Ha, H.G. Kim, Y.S. Yi, J.H. Kim, K.S. Baek, N.Y. Sung, M.N. Lee, J.H. Kim, J.Y. Cho, Kaempferol, a dietary flavonoid, ameliorates acute inflammatory and nociceptive symptoms in gastritis, pancreatitis, and abdominal pain, Mol Nutr Food Res 59(7) (2015) 1400-5.
23 Y.J. Lee, K.S. Suh, M.C. Choi, S. Chon, S. Oh, J.T. Woo, S.W. Kim, J.W. Kim, Y.S. Kim, Kaempferol protects HIT-T15 pancreatic beta cells from 2-deoxy-D-ribose-induced oxidative damage, Phytother Res 24(3) (2010) 419-23.
24 M. Scotece, J. Conde, V. Abella, V. Lopez, V. Francisco, C. Ruiz, V. Campos, F. Lago, R. Gomez, J. Pino, O. Gualillo, Oleocanthal Inhibits Catabolic and Inflammatory Mediators in LPS-Activated Human Primary Osteoarthritis (OA) Chondrocytes Through MAPKs/NF-kappaB Pathways, Cell Physiol Biochem 49(6) (2018) 2414-2426.
25 M. Drosten, M. Barbacid, Targeting the MAPK Pathway in KRAS-Driven Tumors, Cancer Cell 37(4) (2020) 543-550.
26 M.H. Cao, J. Xu, H.D. Cai, Z.W. Lv, Y.J. Feng, K. Li, C.Q. Chen, Y.Y. Li, p38 MAPK inhibition alleviates experimental acute pancreatitis in mice, Hepatobiliary Pancreat Dis Int 14(1) (2015) 101-6.
27 Z. Zhang, Q. Liu, H. Zang, Q. Shao, T. Sun, Oxymatrine protects against l-arginine-induced acute pancreatitis and intestine injury involving Th1/Th17 cytokines and MAPK/NF-kappaB signalling, Pharm Biol 57(1) (2019) 595-603.
28 X.P. Zeng, L.J. Wang, H.L. Guo, L. He, Y.W. Bi, Z.L. Xu, Z.S. Li, L.H. Hu, Dasatinib ameliorates chronic pancreatitis induced by caerulein via anti-fibrotic and anti-inflammatory mechanism, Pharmacol Res 147 (2019) 104357.
29 S. Perez, S. Rius-Perez, I. Finamor, P. Marti-Andres, I. Prieto, R. Garcia, M. Monsalve, J. Sastre, Obesity causes PGC-1alpha deficiency in the pancreas leading to marked IL-6 upregulation via NF-kappaB in acute pancreatitis, J Pathol 247(1) (2019) 48-59.
30 Y. Wang, C. Bu, K. Wu, R. Wang, J. Wang, Curcumin protects the pancreas from acute pancreatitis via the mitogenactivated protein kinase signaling pathway, Mol Med Rep 20(4) (2019) 3027-3034.
31 H. Zhang, P. Neuhofer, L. Song, B. Rabe, M. Lesina, M.U. Kurkowski, M. Treiber, T. Wartmann, S. Regner, H. Thorlacius, D. Saur, G. Weirich, A. Yoshimura, W. Halangk, J.P. Mizgerd, R.M. Schmid, S. Rose-John, H. Algul, IL-6 trans-signaling promotes pancreatitis-associated lung injury and lethality, J Clin Invest 123(3) (2013) 1019-31.
32 W.M. Kamp, P.Y. Wang, P.M. Hwang, TP53 mutation, mitochondria and cancer, Curr Opin Genet Dev 38 (2016) 16-22.
33 L. Singh, D.K. Bakshi, S. Majumdar, S.K. Arora, R.K. Vasishta, J.D. Wig, Mitochondrial dysfunction and apoptosis of acinar cells in chronic pancreatitis, J Gastroenterol 43(6) (2008) 473-83.
34 L. Zhou, J.H. Tan, R.C. Cao, J. Xu, X.M. Chen, Z.C. Qi, S.Y. Zhou, S.B. Li, Q.X. Mo, Z.W. Li, G.W. Zhang, ATF6 regulates the development of chronic pancreatitis by inducing p53-mediated apoptosis, Cell Death Dis 10(9) (2019) 662.
35 J. Li, X. Ma, C. Liu, H. Li, J. Zhuang, C. Gao, C. Zhou, L. Liu, K. Wang, C. Sun, Exploring the Mechanism of Danshen against Myelofibrosis by Network Pharmacology and Molecular Docking, Evid Based Complement Alternat Med 2018 (2018) 8363295.